Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
2017 · The Lancet · 3,118 citations
https://doi.org/10.1016/s0140-6736(16)32401-1
R
Rhian Gabe
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
199
Papers
8.4K
Citations
35
h-index
62
i10-index
Rhian Gabe is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Global Cancer Incidence and Screening & Diagnosis and Treatment of Venous Diseases. The author has an h-index of 35, co-authored 170 publications.
ORCID: 0000-0002-0273-3094Papers by this author
worksLung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysis
2021 · The Lancet Regional Health - Europe · 209 citations
https://doi.org/10.1016/j.lanepe.2021.100179
Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
2014 · JNCI Journal of the National Cancer Institute · 138 citations
https://doi.org/10.1093/jnci/dju169
CollAborative care for Screen-Positive EldeRs with major depression (CASPER plus): a multicentred randomised controlled trial of clinical effectiveness and cost-effectiveness
2017 · Health Technology Assessment · 77 citations
https://doi.org/10.3310/hta21670
Validation of the VEINES-QOL quality of life instrument in venous leg ulcers: repeatability and validity study embedded in a randomised clinical trial
2015 · BMC Cardiovascular Disorders · 73 citations
https://doi.org/10.1186/s12872-015-0080-7
Liverpool Lung Project lung cancer risk stratification model: calibration and prospective validation
2020 · Thorax · 62 citations
https://doi.org/10.1136/thoraxjnl-2020-215158
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat